Health ❯ Healthcare ❯ Vaccines

mRNA Technology

Pandemic Preparedness Moderna COVID-19 Vaccines Vaccine Development Flu Vaccines Public Health Cancer Treatment Personalized Medicine Cancer Vaccines Flu Vaccine Public Health Decisions Cancer Applications Public Health Risks Moderna Vaccines Regulatory Affairs Public Health Concerns Bird Flu Vaccine Public Health Policy Seasonal Flu Vaccine Influenza Vaccines Operation Warp Speed Cancer Research COVID-19 Adverse Effects COVID-19 Response

46 ARTICLES

4w ago

FDA Approves Moderna’s mFlusiva for Adults 50 and Older

The authorization brings the first U.S.‑licensed mRNA seasonal flu vaccine but its public rollout is uncertain because the CDC advisory panel cannot meet to set formal recommendations.

14 ARTICLES

2mo ago

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

7 ARTICLES

last yr.

RFK Jr. Pulls $500M From mRNA Vaccine Projects, Draws Sharp Criticism

mRNA Technology

FDA Approves Moderna’s mFlusiva for Adults 50 and Older

FDA Advisers Unanimously Back Moderna’s mRNA Flu Vaccine

FDA Panel Weighs Moderna’s Bid for First U.S. mRNA Flu Vaccine

Moderna Restructures Leadership as It Prepares for Multiple Vaccine Launches

Moderna Begins Phase III Trial of mRNA Bird Flu Vaccine in UK and US

FDA to Review Moderna’s Flu Shot as Shares Rally on Earnings Beat

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

RFK Jr. Pulls $500M From mRNA Vaccine Projects, Draws Sharp Criticism